News
'Dismal' survival demands change in bile duct cancer therapy
International cancer experts have called for big changes to bile duct cancer, which kills three-quarters of patients within a year of diagnosis.
News
CHMP backs Ipsen drug for childhood brain cancer
Ipsen's Ojemda is on course to become the first targeted medicine in the EU for some children with a form of brain cancer known as low-grade glioma.
News
Boehringer gets FDA's second 'national priority' approval
Boehringer Ingelheim's lung cancer drug Hernexeos has become the second medicine approved after an FDA national priority review.
News
Generate's IPO gets over the line, raising $400m
AI-powered drug developer Generate Biomedicine completes a $400m IPO, the largest for biotech on the Nasdaq so far this year.
News
Eisai unveils digital platform for kidney cancer patients
Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
